Jocelyn Ulrich
Vice President of Policy and Research at PhRMA
About
Jocelyn Ulrich’s work at PhRMA focuses on policy analysis related to pharmaceutical innovation, including patent issues, FDA matters, and the process of developing new medicines. Before PhRMA, Ulrich held pharmaceutical-industry roles at Pfizer, Human Genome Sciences, and EMD Serono.
Upcoming events (0)
No upcoming events are listed for this speaker.
Organizers
Organizations behind the events this speaker has appeared at.
Past events (1)
SEP
30
WED
An expert panel examines China’s growing competition with the United States in biopharmaceutical innovation, including scientific research, drug development, clinical trials, manufacturing, and broader industry competitiveness. Discussion topics include the drivers of China’s rise, areas where China has gained ground, remaining U.S. advantages, the distinction between legitimate investment and unfair practices such as industrial subsidies and intellectual property theft, and policies to strengthen American innovation, critical manufacturing capabilities, supply chains, cooperation with allies, and domestic development of breakthrough medicines.